Table 1 Patient and Sample Characteristics.
Characteristics | Patients (N = 116)* |
|---|---|
Age, years (n = 115) | |
Median (interquartile range) | 53.0 (45.5–64.5) |
Distribution | |
≤40 | 15 (13) |
41–50 | 40 (35) |
51–60 | 20 (17) |
61–70 | 23 (20) |
>70 | 17 (15) |
Pathologic stage (n = 112) | |
I | 33 (29) |
II | 57 (51) |
III | 19 (17) |
IV | 3 (3) |
Histologic grade of tumor (n = 113) | |
Low | 17 (15) |
Intermediate | 60 (53) |
High | 36 (32) |
Estrogen receptor expression (n = 114) | |
Negative | 32 (28) |
Positive | 82 (72) |
Progesterone receptor expression (n = 114) | |
Negative | 51 (45) |
Positive | 63 (55) |
Human epidermal growth factor 2 receptor expression | |
Negative | 78 (73) |
Positive | 29 (27) |
Immunohistochemical classification (n = 107) | |
HR + /HER2- | 64 (60) |
HR + /HER2+ | 13 (12) |
HER2+ | 16 (15) |
TNBC | 14 (13) |
